# Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's Disease

> **NCT02787590** · PHASE2 · COMPLETED · sponsor: **University Hospital Plymouth NHS Trust** · enrollment: 235 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** Matched Placebo (for Simvastatin)

## Key facts

- **NCT ID:** NCT02787590
- **Lead sponsor:** University Hospital Plymouth NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-08
- **Primary completion:** 2019-11-01
- **Final completion:** 2020-12-31
- **Target enrollment:** 235 (ACTUAL)
- **Last updated:** 2021-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02787590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02787590, "Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02787590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*